Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 84 citing Hogan: Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-asso.... (0.08 sec) 

A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel …


MS Joy, SL Hogan, JC Jennette, RJ Falk, … - Nephrology Dialysis Transplantation, 2005 - ERA-EDTA
Results. Twelve subjects were enrolled in the study. Treatment with MMF led to
an improvement in disease activity as measured by the BVAS at 24 weeks (P =
0.0013) and 52 weeks (P = 0.0044) as compared to baseline. The BVAS ...
Cited by 50 - Related articles - BL Direct - All 6 versions

Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis


CGM Kallenberg - Current opinion in rheumatology, 2007 - journals.lww.com
Recent findings: Antineutrophil cytoplasmic autoantibodies are closely
associated with Wegener's granulomatosis and microscopic polyangiitis. Within
the Churg-Strauss syndrome, antineutrophil cytoplasmic autoantibodies, ...
Cited by 27 - Related articles - BL Direct - All 4 versions

BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis

- oxfordjournals.org
C Lapraik, R Watts, P Bacon, D Carruthers, K … - Rheumatology, 2007 - Br Soc Rheumatology
1 Department of Rheumatology, Norfolk and Norwich University Hospital, Norwich,
2 School of Medicine Health Policy and Practice, University of East Anglia,
Norwich, UK, 3 Department of Rheumatology, Ipswich Hospital NHS Trust, ...
Cited by 22 - Related articles - BL Direct - All 9 versions

[PDF] Intravenous immunoglobulins for relapses of systemic vasculitides associated with …


V Martinez, P Cohen, C Pagnoux, S Vinzio, A … - Arthritis Rheum, 2008 - assets0.pubget.com
Objective. To evaluate at 9 months and 24 months the safety and efficacy of
intravenous immunoglobulins (IVIGs) administered for 6 months to treat relapses
of Wegener's granulomatosis (WG) or microscopic polyan- giitis (MPA) ...
Cited by 22 - Related articles - View as HTML - BL Direct - All 2 versions

Is there a role for TNF-{alpha} in anti-neutrophil cytoplasmic antibody-associated …

- asnjournals.org
M Feldmann, CD Pusey - Journal of the American Society of Nephrology, 2006 - Am Soc Nephrol
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is the most
common cause of rapidly progressive glomerulonephritis and immune-mediated
pulmonary renal syndrome. Now that the acute manifestations of the disease ...
Cited by 20 - Related articles - BL Direct - All 5 versions

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a …


C Mukhtyar, O Flossmann, B Hellmich, P Bacon … - British Medical Journal, 2008 - ard.bmj.com
Results: A total of 44 papers were reviewed from 502 identified by our search
criteria. There was considerable inconsistency in definitions of end points.
Remission rates varied from 30% to 93% in Wegener granulomatosis (WG), 75% ...
Cited by 15 - Related articles - All 3 versions

Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel …

- asnjournals.org
SL Hogan, GS Cooper, DA Savitz, LA Nylander- … - Clinical Journal of the American Society of Nephrology, 2007 - Am Soc Nephrol
Anti–neutrophil cytoplasmic autoantibodies (ANCA) are associated with a
category of small-vessel vasculitis (SVV) with frequent glomerulonephritis. The
goal of this study was to evaluate the association of lifetime silica ...
Cited by 14 - Related articles - BL Direct - All 3 versions

Anti-myeloperoxidase and anti-cathepsin G antibodies in sulphonamide hypersensitivity


SN Lavergne, NJ Drescher, LA Trepanier - Clinical and Experimental Allergy, 2008 - pt.wkhealth.com
Cited by 12 - Related articles - BL Direct - All 5 versions

Azathioprine or methotrexate maintenance for ANCA-associated vasculitis

- mynrma.com.au [PDF] 
C Pagnoux, A Mahr, MA Hamidou, JJ Boffa, M … - New England Journal of Medicine, 2008 - content.nejm.org
From Université Paris Descartes, Hôpital Cochin, Assistance
Publique–Hôpitaux de Paris (CP, AM, PC, LM, LG), Hôpi- tal Tenon (J.-JB),
and Hôpital Bichat– Claude-Bernard (TP) — all in Paris; Cen- tre ...
Cited by 11 - Related articles - All 7 versions

Recurrences and infections during continuous immunosuppressive therapy after beginning …


F Weidanz, CJ Day, P Hewins, CO Savage, L … - American Journal of Kidney Diseases, 2007 - Elsevier
Approximately 20% of patients with antineutrophil cytoplasm
antibody–associated systemic vasculitis (AASV) develop end-stage renal failure
(ESRF). It is not clear whether continuation of immunosuppression, with its ...
Cited by 9 - Related articles - All 18 versions


Result Page: 

1

2

3

4

5

6

7

8

9

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google